206 related articles for article (PubMed ID: 15197663)
1. Drug evaluation: Bay-59-8862.
Eckstein JW
IDrugs; 2004 Jun; 7(6):575-81. PubMed ID: 15197663
[TBL] [Abstract][Full Text] [Related]
2. Taxane effect in a bladder washing.
Dustin SM; Jeffus SK; Stelow EB
Diagn Cytopathol; 2015 Jan; 43(1):32-3. PubMed ID: 24644138
[No Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of methoxylated analogs of the newer generation taxoids IDN5109 and IDN5390.
Barboni L; Ballini R; Giarlo G; Appendino G; Fontana G; Bombardelli E
Bioorg Med Chem Lett; 2005 Dec; 15(23):5182-6. PubMed ID: 16183281
[TBL] [Abstract][Full Text] [Related]
4. GM1 for taxane-induced neuropathy in breast cancer.
Das M
Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320
[No Abstract] [Full Text] [Related]
5. Updates in anti-HER2 combination therapy.
Burstein H
Clin Adv Hematol Oncol; 2008 Dec; 6(12):873-4. PubMed ID: 19209136
[No Abstract] [Full Text] [Related]
6. The discovery of BMS-275183: an orally efficacious novel taxane.
Mastalerz H; Cook D; Fairchild CR; Hansel S; Johnson W; Kadow JF; Long BH; Rose WC; Tarrant J; Wu MJ; Xue MQ; Zhang G; Zoeckler M; Vyas DM
Bioorg Med Chem; 2003 Oct; 11(20):4315-23. PubMed ID: 13129567
[TBL] [Abstract][Full Text] [Related]
7. IDN5109, a taxane with oral bioavailability and potent antitumor activity.
Nicoletti MI; Colombo T; Rossi C; Monardo C; Stura S; Zucchetti M; Riva A; Morazzoni P; Donati MB; Bombardelli E; D'Incalci M; Giavazzi R
Cancer Res; 2000 Feb; 60(4):842-6. PubMed ID: 10706091
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of C-13, C-14 modified taxane analogues from 1-deoxybaccatin VI.
Tang P; Lin HX; Yuan TH; Cui YM
Nat Prod Res; 2019 Dec; 33(24):3478-3484. PubMed ID: 29897250
[TBL] [Abstract][Full Text] [Related]
9. Survival following the documentation of platinum and taxane resistance in ovarian cancer.
Büyükçelik A; Yalçin B; Utkan G; Doruk H
Gynecol Oncol; 2004 Dec; 95(3):774-5; author reply 775-6. PubMed ID: 15582006
[No Abstract] [Full Text] [Related]
10. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.
Cardonick E; Bhat A; Gilmandyar D; Somer R
Ann Oncol; 2012 Dec; 23(12):3016-3023. PubMed ID: 22875836
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1.
Walker K; Kibble A; Shumoogam J
IDrugs; 2007 Aug; 10(8):513-6. PubMed ID: 17665320
[No Abstract] [Full Text] [Related]
12. [Acute typhlitis associated with taxane-based chemotherapy].
Gagliano E; Tonante A; Taranto F; Mamo M; Sturniolo G; Colonese F; Sturniolo G
G Chir; 2010; 31(11-12):514-7. PubMed ID: 21232195
[TBL] [Abstract][Full Text] [Related]
13. Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.
De Iuliis F; Salerno G; Taglieri L; Scarpa S
Cancer Chemother Pharmacol; 2015 Oct; 76(4):679-90. PubMed ID: 26198313
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia and Noncoding RNAs in Taxane Resistance.
Pucci P; Rescigno P; Sumanasuriya S; de Bono J; Crea F
Trends Pharmacol Sci; 2018 Aug; 39(8):695-709. PubMed ID: 29891252
[TBL] [Abstract][Full Text] [Related]
15. Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative.
Roche M; Kyriakou H; Seiden M
Curr Opin Investig Drugs; 2006 Dec; 7(12):1092-9. PubMed ID: 17209527
[TBL] [Abstract][Full Text] [Related]
16. Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport.
Xiao X; Wu J; Trigili C; Chen H; Chu JW; Zhao Y; Lu P; Sheng L; Li Y; Sharom FJ; Barasoain I; Diaz JF; Fang WS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4852-6. PubMed ID: 21764308
[TBL] [Abstract][Full Text] [Related]
17. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Sparano JA
Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
[TBL] [Abstract][Full Text] [Related]
18. Taxane-induced scleroderma-like skin changes resulting in gangrene: A case report.
Ogawa T; Okiyama N; Koguchi-Yoshioka H; Fujimoto M
J Dermatol; 2017 Apr; 44(4):e54-e55. PubMed ID: 27600439
[No Abstract] [Full Text] [Related]
19. Innovative antineoplastic agents.
Wood L
J Intraven Nurs; 2001; 24(1):48-55. PubMed ID: 11836844
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy.
Wampler MA; Topp KS; Miaskowski C; Byl NN; Rugo HS; Hamel K
Arch Phys Med Rehabil; 2007 Aug; 88(8):1002-8. PubMed ID: 17678662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
